Starling Oncology, Inc. Warrant
STLNW
11 hedge funds and large institutions have $536K invested in Starling Oncology, Inc. Warrant in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.44% more ownership
Funds ownership: 0% → 1.44% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
+$89.7K |
| 2 |
MCM
Moore Capital Management
New York
|
+$89.7K |
| 3 |
JG
Jefferies Group
New York
|
+$71.9K |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$71.7K |
| 5 |
OCAM
Owl Creek Asset Management
New York
|
+$71.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FTCM
1
Fir Tree Capital Management
New York
| $93K | +$89.7K | +62,500 | New |
|
|
MCM
2
Moore Capital Management
New York
| $91K | +$89.7K | +62,500 | New |
|
|
PMAM
3
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| $74K | +$71.7K | +50,000 | New |
|
|
OCAM
4
Owl Creek Asset Management
New York
| $73K | +$71.7K | +49,999 | New |
|
5
Hudson Bay Capital Management
Stamford,
Connecticut
| $46K | +$45.8K | +31,959 | New |
|
|
BCM
6
Basso Capital Management
Stamford,
Connecticut
| $38K | +$37.5K | +26,160 | New |
|
|
LA
7
Linden Advisors
New York
| $37K | +$35.9K | +24,998 | New |
|
|
TCM
8
Tenor Capital Management
New York
| $37K | +$35.9K | +25,000 | New |
|
|
MIM
9
Monashee Investment Management
Boston,
Massachusetts
| $28K | +$26.9K | +18,749 | New |
|
|
DCM
10
Dupont Capital Management
Wilmington,
Delaware
| $19K | +$17.9K | +12,500 | New |
|
|
JG
11
Jefferies Group
New York
| $74 | +$71.9K | +50,125 | New |
|
STLNW Hedge Fund Activity: Q2 2020 in Review
11 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q2 2020, worth a combined $536K.
Buyers outnumbered sellers: 11 funds opened new STLNW positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fir Tree Capital Management, opening a new position worth an estimated $89.7K.
- 11 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $536K of Starling Oncology, Inc. Warrant stock for Q2 2020.
- 11 funds opened new Starling Oncology, Inc. Warrant positions in Q2 2020 and 0 closed out, a net change of +11 holders.
- The largest Starling Oncology, Inc. Warrant buyer in Q2 2020 was Fir Tree Capital Management, an estimated $89.7K added.
Based on aggregated 13F filings for Q2 2020.